Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

Sign InCreate free account
GSK plc logo
GSK.L
GSK plc
13:26:33
1936.5 £
0.0000 (%0.00)
Previous Close: 1923
Day Low₺1917.5
Day High₺1942.5
Bid
Ask
Overview
Technicals
Financial Statements
Comments
Archive

GSK.L: GSK plc Financials

GSK plc Income Statement

Total revenue
Net income
Gross margin TTM
72.54%
Operating margin TTM
21.95%
Net profit margin TTM
17.5%
Return on investment TTM
34.9%
Period end31/12/202531/12/202431/12/202331/12/2022
Total revenue32,667,000,00031,376,000,00030,328,000,00029,324,000,000
Operating income7,169,000,0005,662,000,0006,993,000,0006,682,000,000
Net income5,716,000,0002,575,000,0004,928,000,00014,956,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Total revenue32,667,000,00031,376,000,00030,328,000,00029,324,000,000
Cost of revenue8,969,000,0009,476,000,0009,076,000,0009,862,000,000
Gross profit23,698,000,00021,900,000,00021,252,000,00019,462,000,000
Research and development expenses7,508,000,0005,497,000,0005,245,000,0004,836,000,000
General and administrative expenses0000
Selling and marketing expenses0000
Selling, general and administrative expenses9,021,000,00010,741,000,0009,014,000,0007,944,000,000
Other expenses0000
Operating expenses16,529,000,00016,238,000,00014,259,000,00012,780,000,000
Cost and expenses25,498,000,00025,714,000,00023,335,000,00022,642,000,000
Net interest income-532,000,000-578,000,000-720,000,000-788,000,000
Interest income169,000,00066,000,00055,000,00064,000,000
Interest expense701,000,000644,000,000775,000,000852,000,000
Depreciation and amortization3,778,000,0002,551,000,0002,294,000,0002,147,000,000
EBITDA11,883,000,0006,675,000,0009,138,000,0008,629,000,000
EBIT8,105,000,0004,124,000,0006,844,000,0006,482,000,000
Non-operating income (excl. interest)-936,000,0001,538,000,000149,000,000200,000,000
Operating income7,169,000,0005,662,000,0006,993,000,0006,682,000,000
Total other income/expenses (net)232,000,000-2,185,000,000-929,000,000-1,054,000,000
Income before tax7,401,000,0003,477,000,0006,064,000,0005,628,000,000
Income tax expense1,112,000,000526,000,000756,000,000707,000,000
Net income from continuing operations6,289,000,0002,951,000,0005,308,000,0004,921,000,000
Net income from discontinued operations00010,495,000,000
Other adjustments to net income0000
Net income5,716,000,0002,575,000,0004,928,000,00014,956,000,000
Net income deductions0000
Bottom line net income5,716,000,0002,575,000,0004,928,000,00014,956,000,000
EPS10.631614
Diluted EPS10.621714
Weighted average shares outstanding4,051,000,0004,077,000,0004,052,000,0004,026,000,000
Weighted average diluted shares outstanding4,117,000,0004,142,000,0004,111,000,0004,084,000,000

GSK plc Balance Sheet

Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
14,015,000,000%
Total debt / assets MRQ
—
Period end31/12/202531/12/202431/12/202331/12/2022
Total assets61,118,000,00059,463,000,00059,005,000,00060,146,000,000
Total liabilities45,162,000,00046,377,000,00046,210,000,00050,050,000,000
Total equity16,377,000,00013,671,000,00013,347,000,00010,598,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Cash and cash equivalents3,150,000,0003,693,000,0002,746,000,0003,523,000,000
Short-term investments9,000,00021,000,0002,246,000,0004,154,000,000
Cash and short-term investments3,159,000,0003,714,000,0004,992,000,0007,677,000,000
Net receivables6,575,000,0005,999,000,0006,465,000,0006,218,000,000
Accounts receivable5,913,000,0005,563,000,0005,905,000,0005,452,000,000
Other receivables662,000,000436,000,000560,000,000766,000,000
Inventory5,924,000,0005,669,000,0005,498,000,0005,146,000,000
Prepaid expenses385,000,000390,000,000355,000,000343,000,000
Other current assets1,467,000,0001,225,000,0001,334,000,0001,385,000,000
Total current assets17,510,000,00016,997,000,00018,644,000,00020,769,000,000
Property, plant and equipment (net)10,048,000,00010,073,000,0009,957,000,0009,620,000,000
Goodwill7,018,000,0006,982,000,0006,811,000,0007,046,000,000
Intangible assets16,748,000,00015,515,000,00014,768,000,00014,318,000,000
Goodwill and intangible assets23,766,000,00022,497,000,00021,579,000,00021,364,000,000
Long-term investments2,159,000,0002,241,000,0002,142,000,0002,506,000,000
Tax assets6,520,000,0006,757,000,0006,049,000,0005,658,000,000
Other non-current assets1,115,000,000898,000,000634,000,000229,000,000
Total non-current assets43,608,000,00042,466,000,00040,361,000,00039,377,000,000
Other assets0000
Total assets61,118,000,00059,463,000,00059,005,000,00060,146,000,000
Total payables4,471,000,0004,585,000,0004,563,000,0004,755,000,000
Accounts payable3,535,000,0003,462,000,0003,717,000,0003,866,000,000
Other payables936,000,0001,123,000,000846,000,000889,000,000
Accrued expenses0000
Short-term debt2,875,000,0002,181,000,0002,657,000,0003,785,000,000
Capital lease obligations (current)137,000,000168,000,000156,000,000167,000,000
Tax payables0703,000,000500,000,000471,000,000
Deferred revenue0000
Other current liabilities13,908,000,00014,763,000,00013,692,000,00014,103,000,000
Total current liabilities21,391,000,00021,697,000,00021,068,000,00022,810,000,000
Long-term debt14,015,000,00013,703,000,00014,154,000,00016,194,000,000
Capital lease obligations (non-current)693,000,000934,000,0001,051,000,000841,000,000
Deferred revenue (non-current)121,000,000165,000,000254,000,00083,000,000
Deferred tax liabilities (non-current)291,000,000382,000,000311,000,000289,000,000
Other non-current liabilities8,651,000,0009,496,000,0009,372,000,0009,833,000,000
Total non-current liabilities23,771,000,00024,680,000,00025,142,000,00027,240,000,000
Other liabilities0000
Capital lease obligations830,000,0001,102,000,0001,207,000,0001,008,000,000
Total liabilities45,162,000,00046,377,000,00046,210,000,00050,050,000,000
Treasury stock0000
Preferred stock0000
Common stock1,349,000,0001,348,000,0001,348,000,0001,347,000,000
Retained earnings10,209,000,0007,796,000,0007,239,000,0004,363,000,000
Additional paid-in capital3,498,000,0003,473,000,0003,451,000,0003,440,000,000
Accumulated other comprehensive income/loss0000
Other stockholders' equity1,321,000,0001,054,000,0001,309,000,0001,448,000,000
Total stockholders' equity16,377,000,00013,671,000,00013,347,000,00010,598,000,000
Total equity15,956,000,00013,086,000,00012,795,000,00010,096,000,000
Minority interest-421,000,000-585,000,000-552,000,000-502,000,000
Total liabilities and total equity61,118,000,00059,463,000,00059,005,000,00060,146,000,000
Total investments2,168,000,0002,262,000,0004,388,000,0006,660,000,000
Total debt17,720,000,00016,986,000,00018,018,000,00020,987,000,000
Net debt14,570,000,00013,293,000,00015,272,000,00017,464,000,000

GSK plc Cash Flow Statement

Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
Period end31/12/202531/12/202431/12/202331/12/2022
Cash from operations7,303,000,0006,554,000,0006,768,000,0007,403,000,000
Cash from investing-5,851,000,000-1,229,000,000-1,595,000,000-8,772,000,000
Cash from financing-1,629,000,000-4,726,000,000-5,641,000,000823,000,000
Net change in cash-473,000,000545,000,000-567,000,000-394,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Net income5,716,000,0002,951,000,0004,928,000,0004,921,000,000
Depreciation and amortization3,778,000,0002,551,000,0002,294,000,0002,298,000,000
Deferred income tax00-865,000,000-784,000,000
Stock-based compensation0344,000,000307,000,000346,000,000
Change in working capital-622,000,000256,000,000-841,000,000271,000,000
Accounts receivable0340,000,000-649,000,000-616,000,000
Inventory0-294,000,000-424,000,000-269,000,000
Accounts payable0-179,000,000-15,000,000494,000,000
Other working capital-622,000,000389,000,000247,000,000662,000,000
Other non-cash items-1,569,000,000452,000,000945,000,000351,000,000
Net cash from operating activities7,303,000,0006,554,000,0006,768,000,0007,403,000,000
Investments in property, plant and equipment-2,985,000,000-1,399,000,000-1,314,000,000-2,258,000,000
Acquisitions (net)-4,466,000,0001,368,000,000-1,468,000,000-3,136,000,000
Purchases of investments-92,000,0000-123,000,000-144,000,000
Sales/maturities of investments200,000,00021,000,00072,000,0001,000,000
Other investing activities1,492,000,000-1,219,000,0001,238,000,000-3,235,000,000
Net cash from investing activities-5,851,000,000-1,229,000,000-1,595,000,000-8,772,000,000
Net debt issuance1,506,000,000-1,166,000,000-2,370,000,000-4,622,000,000
Long-term net debt issuance579,000,000-540,000,00079,000,000-569,000,000
Short-term net debt issuance927,000,000-626,000,000-2,449,000,000-4,053,000,000
Net stock issuance15,000,00020,000,00010,000,00025,000,000
Net common stock issuance15,000,00020,000,00010,000,00025,000,000
Common stock issuance15,000,00020,000,00010,000,00025,000,000
Common stock repurchased0000
Net preferred stock issuance0000
Net dividends paid-2,564,000,000-2,444,000,000-2,247,000,000-3,467,000,000
Common dividends paid-2,564,000,000-2,444,000,000-2,247,000,000-3,467,000,000
Preferred dividends paid0000
Other financing activities-586,000,000-1,136,000,000-1,034,000,0008,887,000,000
Net cash from financing activities-1,629,000,000-4,726,000,000-5,641,000,000823,000,000
Effect of FX changes on cash-296,000,000-54,000,000-99,000,000152,000,000
Net change in cash-473,000,000545,000,000-567,000,000-394,000,000
Cash at end of period3,397,000,0003,403,000,0002,858,000,0003,425,000,000
Cash at beginning of period3,870,000,0002,858,000,0003,425,000,0003,819,000,000
Operating cash flow7,303,000,0006,554,000,0006,768,000,0007,403,000,000
Capital expenditure-1,348,000,000-2,982,000,000-2,344,000,000-2,258,000,000
Free cash flow5,955,000,0003,572,000,0004,424,000,0005,145,000,000
Income taxes paid0000
Interest paid0000